World Infectious Disease Diagnostic Testing Market Research Report 2022
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Infectious Disease Diagnostic Testing: World Market Analysis" report has been added to ResearchAndMarkets.com's offering.
This report examines the global market for infectious disease testing products.
The report also examines the global demand for infectious disease IVD products, which is projected to increase as medical providers and healthcare organizations throughout the world heighten efforts to combat proliferating epidemic threats.
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine appropriate antimicrobial therapy.
Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques. Specific types of tests are available for detecting hundreds of pathogenic conditions.
Market Drivers
The report examines market drivers, including external market influences that are promoting the development and use of improved infectious disease diagnostics.
Public health officials worldwide have begun to recognize the global nature of infectious diseases - they are no longer solely a problem of developing countries but touch the very fabric of the social and economic welfare of countries in the industrialized world as well.
Over the long term, aging populations and problems posed by infectious diseases will strain healthcare resources in many countries.
Specific applications analyzed include:
Healthcare-associated and opportunistic infections
Antimicrobial-resistant pathogens including bacteria, fungi, parasites, and viruses
Human immunodeficiency virus (HIV) and hepatitis viruses
Diseases related to women's health and sexually transmitted infections (STDs)
Emerging, neglected, and tropical disease threats
Respiratory tract infections and respiratory viruses (including COVID-19)
Competitive Landscape
The report details the major competitors that are global market leaders in infectious disease testing products and technologies, including an overview and an outline of these company's infectious disease IVD products:
Abbott Laboratories
Becton, Dickinson and Company (BD)
bioMerieux Inc.
Bio-Rad Laboratories, Inc.
Bruker Corporation
DiaSorin S.p.A.
Grifols
Hologic, Inc.
Ortho-Clinical Diagnostics
QIAGEN N.V.
Quidel Corporation
Roche
Siemens AG
Thermo Fisher Scientific Inc.
Key Topics Covered:
Chapter 1: Executive Summary
A Mix of Traditional and Emerging Testing Technologies
Market Drivers
The World Infectious Disease Testing Market
Major Findings of the Report
Scope and Methodology
Chapter 2: Market Environment
Overview
Population
Age Distribution
Macroeconomic Environment
Global Economic Outlook
Per Capita Gross Domestic Product
Global Healthcare Trends
Infectious Disease Cases
Medical Providers
Patient Activity
Hospital Admissions
Inpatient Days
Surgical Procedures
Outpatient Consultations
IVD Tests
Chapter 3: Infectious Disease IVD Products & Markets
Overview
Sexually Transmitted Infections (STIs)
Chlamydia Trachomatis (chlamydia)
Human Papillomavirus (HPV)
Gonorrhea
Herpes Simplex Virus 2 (HSV-2)
Syphilis
Other Sexually Transmitted Disease (STD) IVD Products
Healthcare-Associated Infections
Clostridium difficile (C. diff)
Sepsis
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Vancomycin-Resistant Enterococcus (VRE)
Other HAIs
Identification & Antibiotic Susceptibility Testing (ID/AST) Products
Automated ID/AST Products
Manual Panels & Reagents
Producers
Hepatitis IVD Products
HIV/AIDS IVD Products
Influenza
Tuberculosis (TB)
TORCH
All Other Infectious Disease IVD Products
Malaria
Streptococcal Infections
Fungal Infections
Parasitic Conditions
Lyme Disease
Respiratory Syncytial Virus (RSV)
Emerging Infections
Chikungunya
Dengue Fever
Additional Products
COVID-19
Global Infectious Disease IVD Technologies
Immunoassays
Molecular Technologies
Conventional Microbiology
Global Infectious Disease IVD Demand by Market
Chapter 4: Global Markets
Overview
North America
United States
Canada
Mexico
Western Europe
Germany
France
United Kingdom
Italy
Spain
Other Western Europe
Netherlands
Belgium
Sweden
Austria
Switzerland
Norway
Denmark
Portugal
Ireland
Greece
Finland
All Other Countries & Territories
Asia/Pacific
China
India
Japan
South Korea
Other Asia/Pacific
Indonesia
Australia
Philippines
Thailand
Taiwan
Vietnam
Malaysia
Pakistan
Hong Kong
Singapore
New Zealand
All Other Countries & Territories
Other Regions
Central & South America
Brazil
Argentina
Colombia
Peru
Chile
All Other Countries & Territories
Eastern Europe
Russia
Poland
Romania
Czech Republic
Hungary
All Other Countries
Africa/Middle East
Turkey
Saudi Arabia
Iran
Egypt
Iraq
Nigeria
South Africa
Israel
United Arab Emirates
All Other Countries & Territories
Chapter 5: Company Profiles
Abbott Laboratories
Becton Dickinson and Company
Bio-Rad Laboratories
bioMerieux
Bruker Corporation
Danaher Corporation
DiaSorin
Grifols S.A.
Hologic
Ortho Clinical Diagnostics Holdings
QIAGEN
Quidel Corporation
Roche Holding
Siemens Healthineers
Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/fuajb9
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900